Cubist Systematic Strategies’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-221
| Closed | -$117K | – | 3259 |
|
|
2024
Q1 | $115K | Sell |
221
-10,076
| -98% | -$5.01M | ﹤0.01% | 3232 |
|
|
2023
Q4 | $4.86M | Sell |
10,297
-160,794
| -94% | -$74.4M | 0.03% | 891 |
|
|
2023
Q3 | $74.5M | Buy |
171,091
+11,242
| +7% | +$5.1M | 0.55% | 3 |
|
|
2023
Q2 | $71M | Buy |
159,849
+70,118
| +78% | +$32.3M | 0.47% | 7 |
|
|
2023
Q1 | $41.3M | Buy |
89,731
+39,677
| +79% | +$18.9M | 0.25% | 29 |
|
|
2022
Q4 | $25.7M | Sell |
50,054
-2,233
| -4% | -$1.13M | 0.15% | 81 |
|
|
2022
Q3 | $23.8M | Buy |
52,287
+25,341
| +94% | +$12.1M | 0.13% | 112 |
|
|
2022
Q2 | $13M | Buy |
26,946
+21,548
| +399% | +$10.7M | 0.08% | 293 |
|
|
2022
Q1 | $2.65M | Buy |
5,398
+968
| +22% | +$442K | 0.02% | 1246 |
|
|
2021
Q4 | $2.05M | Sell |
4,430
-17,503
| -80% | -$7.36M | 0.02% | 1351 |
|
|
2021
Q3 | $8.18M | Buy |
21,933
+12,479
| +132% | +$4.74M | 0.1% | 258 |
|
|
2021
Q2 | $3.61M | Sell |
9,454
-20,336
| -68% | -$7.77M | 0.04% | 735 |
|
|
2021
Q1 | $10.7M | Buy |
29,790
+15,174
| +104% | +$4.88M | 0.14% | 142 |
|
|
2020
Q4 | $4.69M | Sell |
14,616
-32,665
| -69% | -$10M | 0.06% | 479 |
|
|
2020
Q3 | $12.7M | Sell |
47,281
-44,480
| -48% | -$12M | 0.19% | 85 |
|
|
2020
Q2 | $24.1M | Buy |
91,761
+28,176
| +44% | +$7.52M | 0.42% | 11 |
|
|
2020
Q1 | $14.4M | Buy |
63,585
+44,743
| +237% | +$12.2M | 0.39% | 30 |
|
|
2019
Q4 | $5.69M | Sell |
18,842
-116,310
| -86% | -$32M | 0.1% | 258 |
|
|
2019
Q3 | $32.5M | Buy |
135,152
+133,641
| +8,845% | +$36.6M | 0.64% | 4 |
|
|
2019
Q2 | $426K | Sell |
1,511
-15,505
| -91% | -$4.24M | 0.01% | 1592 |
|
|
2019
Q1 | $4.88M | Buy |
17,016
+15,364
| +930% | +$4.44M | 0.16% | 137 |
|
|
2018
Q4 | $434K | Buy |
1,652
+624
| +61% | +$172K | 0.02% | 1057 |
|
|
2018
Q3 | $282K | Sell |
1,028
-2,073
| -67% | -$538K | 0.02% | 1204 |
|
|
2018
Q2 | $738K | Sell |
3,101
-8,705
| -74% | -$2.02M | 0.04% | 611 |
|
|
2018
Q1 | $2.59M | Buy |
11,806
+7,046
| +148% | +$1.66M | 0.15% | 154 |
|
|
2017
Q4 | $1.07M | Sell |
4,760
-357
| -7% | -$76K | 0.06% | 442 |
|
|
2017
Q3 | $972K | Buy |
5,117
+435
| +9% | +$82.8K | 0.05% | 447 |
|
|
2017
Q2 | $881K | Buy |
4,682
+194
| +4% | +$34.9K | 0.06% | 484 |
|
|
2017
Q1 | $742K | Sell |
4,488
-9,237
| -67% | -$1.47M | 0.05% | 466 |
|
|
2016
Q4 | $1.97M | Buy |
13,725
+8,768
| +177% | +$1.17M | 0.16% | 151 |
|
|
2016
Q3 | $621K | Sell |
4,957
-1,340
| -21% | -$173K | 0.04% | 623 |
|
|
2016
Q2 | $827K | Sell |
6,297
-2,071
| -25% | -$283K | 0.05% | 523 |
|
|
2016
Q1 | $1.16M | Buy |
8,368
+2,945
| +54% | +$394K | 0.07% | 400 |
|
|
2015
Q4 | $756K | Sell |
5,423
-11,497
| -68% | -$1.58M | 0.04% | 606 |
|
|
2015
Q3 | $2.37M | Sell |
16,920
-10,808
| -39% | -$1.62M | 0.12% | 193 |
|
|
2015
Q2 | $4.55M | Sell |
27,728
-13,060
| -32% | -$2.09M | 0.22% | 81 |
|
|
2015
Q1 | $6.3M | Sell |
40,788
-16,558
| -29% | -$2.36M | 0.31% | 43 |
|
|
2014
Q4 | $7.21M | Buy |
57,346
+47,735
| +497% | +$5.9M | 0.39% | 23 |
|
|
2014
Q3 | $1.15M | Sell |
9,611
-15,090
| -61% | -$1.73M | 0.07% | 387 |
|
|
2014
Q2 | $2.66M | Buy |
+24,701
| New | +$2.55M | 0.16% | 162 |
|
Other funds holding ELV
Cubist Systematic Strategies's ELV Position: Q2 2024 in Review
Cubist Systematic Strategies sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 221 shares — an estimated $117K sold.
Cubist Systematic Strategies first reported a position in ELV in Q2 2014 and held it in 40 quarters. The position peaked at $74.5M in Q3 2023. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.
- Cubist Systematic Strategies reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 221 Elevance Health shares in Q2 2024, an estimated $117K.
- Cubist Systematic Strategies first reported a position in Elevance Health in Q2 2014 and held it in 40 quarters.
- Cubist Systematic Strategies's Elevance Health position peaked at $74.5M in Q3 2023.
- 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.
Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.